| Actimed Therapeutics Ltd.. (4/2/20). "Press Release: Actimed Therapeutics Appoints Annalisa Jenkins as Advisor". London. |
2020-04-02 |
| ERS Genomics Ltd.. (4/2/20). "Press Release: ERS Genomics and Axxam Announce CRISPR/Cas9 License Agreement to Enhance Discovery Services". Dublin & Milan. |
2020-04-02 |
| Danaher Corporation. (3/31/20). "Press Release: Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences, Business Will Be Called Cytiva". Washington, DC. |
2020-03-31 |
| Owlstone Medical Ltd.. (3/30/20). "Press Release: Owlstone Medical Appoints Neil Tween as Chief Financial Officer". Cambridge. |
2020-03-30 |
| ImaginAb, Inc.. (3/30/20). "Press Release: ImaginAb Announces Licensing Deal with AstraZeneca for CD8 ImmunoPET Technology". Los Angeles, CA. |
2020-03-30 |
| Biocat. (3/27/20). "Press Release: Barcelona to Host BIO-Europe Spring 2021". Barcelona. |
2020-03-27 |
| Immune Regulation Ltd.. (3/27/20). "Press Release: Immune Regulation Ltd Appoints Jonathan Rigby as Chief Executive Officer". |
2020-03-27 |
| Bone Therapeutics S.A.. (3/26/20). "Press Release: Bone Therapeutics Appoints Stefanos Theoharis as Chief Business Officer". Gosselies. |
2020-03-26 |
| Evox Therapeutics Ltd.. (3/26/20). "Press Release: Evox Therapeutics and Takeda Sign Multi-target Rare Disease Collaboration". |
2020-03-26 |
| Randox Laboratories Ltd.. (3/26/20). "Press Release: Point of Care Coronavirus Test from Randox and Bosch Will Launch in April 2020". |
2020-03-26 |
| SutroVax, Inc.. (3/26/20). "Press Release: SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia". Foster City, CA. |
2020-03-26 |
| Proteona Pte. Ltd.. (25/3/20). "Press Release: Proteona Leads International Consortium to Develop SARS-CoV-2 Neutralizing Antibody to Help Vulnerable Immunocompromised Individuals". Singapore. |
2020-03-25 |
| Silence Therapeutics plc. (3/25/20). "Press Release: Silence Therapeutics Announces R&D Update". London. |
2020-03-25 |
| Silence Therapeutics plc. (3/25/20). "Press Release: Silence Therapeutics Announces Collaboration with AstraZeneca to Discover and Develop siRNA Therapeutics for Cardiovascular, Renal, Metabolic and Respiratory Diseases". London. |
2020-03-25 |
| Oxford BioMedica plc. (3/18/20). "Press Release: Building the Group for Future Growth. Business Update". Oxford. |
2020-03-18 |
| Oxford BioMedica plc. (3/18/20). "Press Release: Oxford BioMedica Signs License & Clinical Supply Agreement with Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, for LentiVector Platform for CAR-T and TCR-T Therapeutics". Oxford. |
2020-03-18 |
| Affimed N.V.. (3/17/20). "Press Release: Affimed Announces Appointment of Arndt Schottelius, M.D. Ph.D. as Chief Scientific Officer". Heidelberg. |
2020-03-17 |
| Immatics Biotechnologies GmbH. (3/17/20). "Press Release: Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies". Houston, TX & Tübingen. |
2020-03-17 |
| NeoPhore Ltd.. (3/17/20). "Press Release: NeoPhore Appoints Dr Matthew Baker as Chief Executive Officer". Cambridge. |
2020-03-17 |
| Life Sciences Partners (LSP). (3/10/20). "Press Release: LSP Closes Largest Ever European Life Sciences Fund at $600 Million". Amsterdam, Munich & Boston, MA. |
2020-03-10 |
| Genomics plc. (3/9/20). "Press Release: Mitchell Harris Joins Genomics plc as Chief Strategy Officer". Oxford. |
2020-03-09 |
| MolMed S.p.A.. (3/9/20). "Press Release: The Board of Directors Approved the 2019 Full Year Financial Results". Milan. |
2020-03-09 |
| MolMed S.p.A.. (3/6/20). "Press Release: MolMed Signs a Multi-year Agreement and Announces the Beginning of a New Collaboration in the Field of T Cell Therapies". Milan. |
2020-03-06 |
| Voluntis S.A.. (3/4/20). "Press Release: Voluntis Announces Its New Strategic Roadmap. Strategic Prioritization of the Oncology Business". Cambridge, MA & Paris. |
2020-03-04 |
| Evonetix Ltd.. (3/2/20). "Press Release: Evonetix Raises $30 Million USD (£23 Million GBP)". Cambridge. |
2020-03-02 |
| CN Bio Innovations Ltd.. (3/2/20). "Press Release: CN Bio Innovations Raises $9 Million USD (c. £6.9 Million GBP)". Cambridge. |
2020-03-02 |
| Immunocore Ltd.. (3/2/20). "Press Release: Immunocore Secures $130 Million Series B Financing". Oxfordshire & Conshohocken, PA. |
2020-03-02 |
| Thermo Fisher Scientific Inc.. (3/2/20). "Press Release: New Enterprise-Level Chromatography Data System Software Enhances Laboratory Efficiency, Compliance and Standardization". San José, CA. |
2020-03-02 |
| Thermo Fisher Scientific Inc.. (3/2/20). "Press Release: New Advanced Liquid Chromatography System Delivers Productivity, Precision and Compliance in Routine Analyses". Germering. |
2020-03-02 |
| Cambridge Cancer Genomics Ltd.. (2/28/20). "Press Release: Precision-Panc and CCG.ai Partnership". Cambridge & Glasgow. |
2020-02-28 |
| Coulter Partners. (2/26/20). "Press Release: Coulter Partners Secures Chief Scientific Officer for Centogene". |
2020-02-26 |
| FinnGen. (2/25/20). "Press Release: FinnGen Welcomes Janssen and Maze Therapeutics". |
2020-02-25 |
| Domainex Ltd.. (2/25/20). "Press Release: Lunac Therapeutics Selects Domainex as Its Strategic Drug Discovery Partner". Cambridge & Leeds. |
2020-02-25 |
| Bicycle Therapeutics plc. (2/25/20). "Press Release: Bicycle Therapeutics Announces Exclusive Strategic Collaboration with Genentech to Develop and Commercialize Bicycle-based Immuno-oncology Therapies". Cambridge & Boston, MA. |
2020-02-25 |
| Sanofi S.A.. (2/24/20). "Press Release: Sanofi to Create New Industry Leading European Company to Provide Active Pharmaceutical Ingredients (API)". Paris. |
2020-02-24 |
| Immatics Biotechnologies GmbH. (2/20/20). "Press Release: Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies". Tübingen & Houston, TX. |
2020-02-20 |
| CTC North GmbH & Co. KG. (2/20/20). "Press Release: Hope for Hepatitis B Patients. New Research Project to Cure Hepatitis B Patients under the European Horizon 2020 Programme". |
2020-02-20 |
| Optibrium Ltd.. (2/17/20). "Press Release: Optibrium Appoints Dr Tim Hohm as Director of Commercial Strategy and Business Development". Cambridge. |
2020-02-17 |
| Edinburgh Innovations. (2/17/20). "Press Release: Spinout Takes Aim at Treatments for Multiple Sclerosis". |
2020-02-17 |
| PharmaMar S.A.. (2/17/20). "Press Release: PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer". Madrid & Dublin. |
2020-02-17 |
| TrakCel Ltd.. (2/17/20). "Press Release: TrakCel Appoints Dr Fiona Withey as Chief Executive Officer". Cardiff. |
2020-02-17 |
| OMass Therapeutics Ltd.. (2/17/20). "Press Release: OMass Therapeutics Announces £27.5 Million Extended Series A Financing". Oxford. |
2020-02-17 |
| Scottish Enterprise. (2/17/20). "Press Release: Deputy First Minister Announces £9.5 Million to Compete in Global Precision Medicine Industry". |
2020-02-17 |
| o2h Ventures. (2/15/20). "Press Release: o2h Ventures Is Pleased to Announce an Investment in Neurofenix, an Innovative Digital Health Company". Cambridge. |
2020-02-15 |
| o2h Ventures. (2/15/20). "Press Release: o2h Ventures Makes an Investment in Turbine". Cambridge. |
2020-02-15 |
| o2h Ventures. (2/15/20). "Press Release: o2h Ventures Makes an Investment in Pencil Biosciences, a Novel Gene Modulation Biotech". Cambridge. |
2020-02-15 |
| Domainex Ltd.. (2/13/20). "Press Release: Domainex Announces the Appointment of Tom Mander as Chief Executive Officer". Cambridge. |
2020-02-13 |
| Freeline Therapeutics Ltd.. (2/12/20). "Press Release: Freeline Presents Data on Its AAV-based Gene Therapies for Fabry Disease and Gaucher Disease at the 16th annual WORLDSymposium". London. |
2020-02-12 |
| Lexington Communications. (2/12/20). "Press Release: Leading Strategy and Public Affairs Consultancy Opens New Office in Cambridge". |
2020-02-12 |
| ERS Genomics Ltd.. (2/11/20). "Press Release: ERS Genomics and Aelian Biotechnology Announce CRISPR/Cas9 License Agreement Enabling Aelian’s Unique Screening Platform". Dublin & Vienna. |
2020-02-11 |
| ERS Genomics Ltd.. (2/10/20). "Press Release: ERS Genomics Provides Comment on Affirmation of Key CRISPR-Cas9 Patent Involved in European Opposition Proceedings". Dublin. |
2020-02-10 |
| Inato. (2/4/20). "Press Release: Inato Raises $14 Million in Series A Funding from Obvious Ventures, Cathay Innovation, Serena and Fly Ventures". Paris. |
2020-02-04 |
| Freeline Therapeutics Ltd.. (2/4/20). "Press Release: Freeline Appoints Theresa Heggie as Chief Executive". London. |
2020-02-04 |
| Exscientia Ltd.. (1/30/20). "Press Release: Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins Clinical Trial". |
2020-01-30 |
| Coulter Partners. (1/28/20). "Press Release: Coulter Partners Secures Chief Financial Officer for Stilla Technologies". |
2020-01-28 |
| Quench Bio. (1/27/20). "Press Release: Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases". Cambridge, MA. |
2020-01-27 |
| Ervaxx Ltd.. (1/24/20). "Press Release: Ervaxx and Cardiff University Enter Collaboration to Develop novel T-cell and T-cell Receptor-based Immunotherapeutics Targeting Dark Antigens". London. |
2020-01-24 |
| Santhera Pharmaceuticals Holding AG. (1/24/20). "Press Release: Santhera Appoints New Chief Financial Officer". Pratteln. |
2020-01-24 |
| PureTech Health plc. (1/23/20). "Press Release: PureTech Receives $200 Million from Sale of a Minority Portion of Affiliate Shares". |
2020-01-23 |
| iOnctura B.V.. (1/23/20). "Press Release: iOnctura Raises EUR 15 Million in Series A Financing to Progress Its Pipeline into Clinical Development". Amsterdam. |
2020-01-23 |
| Oxford University Innovation. (1/23/20). "Press Release: Oxford Investment Opportunity Network and Oxford Angel Network Join Forces". |
2020-01-23 |
| Coulter Partners. (1/22/20). "Press Release: Coulter Partners Secures Chief Scientific Officer for OxStem". |
2020-01-22 |
| Horizon Therapeutics plc. (1/21/20). "Press Release: FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)". Dublin. |
2020-01-21 |
| Coulter Partners. (1/21/20). "Press Release: Coulter Partners Secures Head of US Sales for Nanoform". |
2020-01-21 |
| Exscientia Ltd.. (1/21/20). "Press Release: Exscientia Appoints Dr. David Hallett as Chief Operating Officer as Company Positions for Further Growth". |
2020-01-21 |
| ERS Genomics Ltd.. (1/17/20). "Press Release: ERS Genomics Provides Comment on EPO Technical Board of Appeal Decision Upholding Revocation of Broad Institute CRISPR Patent". Dublin. |
2020-01-17 |
| Clarivate Analytics plc. (1/17/20). "Press Release: Clarivate Analytics to Acquire Decision Resources Group, Creating a Leading Global Provider of Data-Driven Solutions to the Life Sciences Industry". London & Philadelphia, PA. |
2020-01-17 |
| Charles River Laboratories International, Inc.. (1/16/20). "Press Release: Charles River Laboratories and Fios Genomics Form a Strategic Alliance to Provide Bioinformatics-driven Drug Discovery and Safety Assessment". Wilmington, MA & Edinburgh. |
2020-01-16 |
| Adaptimmune Therapeutics plc. (1/14/20). "Press Release: Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies". Tokyo, Philadelphia, PA & Oxfordshire. |
2020-01-14 |
| BioNTech SE. (1/13/20). "Press Release: BioNTech Appoints Ryan Richardson as Chief Strategy Officer to Support its Continued Global Expansion". Mainz. |
2020-01-13 |
| ERS Genomics Ltd.. (1/13/20). "Press Release: ERS Genomics Licenses CRISPR Gene Editing Technology to Daiichi Sankyo to Support Internal Research and Development". Dublin. |
2020-01-13 |
| Alderaan Biotechnology S.A.S.. (1/9/20). "Press Release: Alderaan Biotechnology Raises €18.5m in Series A from Advent France Biotechnology (AFB) and Medicxi". Paris. |
2020-01-09 |
| Bayer AG. (1/9/20). "Press Release: Bayer and Exscientia Collaborate to Leverage the Potential of Artificial Intelligence in Cardiovascular and Oncology Drug Discovery". Berlin. |
2020-01-09 |
| Emergex Vaccines Holding Ltd.. (1/9/20). "Press Release: Emergex Raises more than US$11 Million in a Series A Round to Progress its Pipeline of Set-point Vaccines for Infectious Diseases". Abingdon. |
2020-01-09 |
| Grey Wolf Therapeutics Ltd.. (1/9/20). "Press Release: Grey Wolf Completes £2.5 Million Series A2 Financing for Development of Therapies Targeting ERAP2". Oxford. |
2020-01-09 |
| Valneva S.E.. (1/9/20). "Press Release: Valneva Expands its Commercial Operations with the Opening of its French Commercial Office". Saint-Herblain. |
2020-01-09 |
| Medicines Discovery Catapult, The. (1/9/20). "Press Release: Hearing Medicines Discovery Syndicate Launches to Fast-track the Development of Hearing Therapeutics". |
2020-01-09 |
| GlaxoSmithKline plc. (1/8/20). "Press Release: Deborah Waterhouse, CEO of ViiV Healthcare, to Join GSK Corporate Executive Team (CET)". London. |
2020-01-08 |
| Avacta Group plc. (1/8/20). "Press Release: Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture". Cambridge & Seoul. |
2020-01-08 |
| Bicycle Therapeutics plc. (1/7/20). "Press Release: Bicycle Therapeutics and Cancer Research UK to Collaborate on Development of New Bicycle Immuno-oncology Candidate, BT7401". London, Cambridge & Boston, MA. |
2020-01-07 |
| MiNA Therapeutics Ltd.. (1/7/20). "Press Release: MiNA Therapeutics Announces Research Collaboration with AstraZeneca in Metabolic Diseases". London. |
2020-01-07 |
| PhoreMost Ltd.. (1/7/20). "Press Release: PhoreMost and Boehringer Ingelheim Enter Multi-project Drug Discovery Collaboration". Cambridge. |
2020-01-07 |
| ERS Genomics Ltd.. (1/7/20). "Press Release: ERS Genomics Announces Agreement with New England Biolabs to Commercialize CRISPR Gene Editing Tools and Reagents". Dublin & Ipswich, MA. |
2020-01-07 |
| Nabriva Therapeutics plc. (12/20/19). "Press Release: Nabriva Therapeutics Resubmits New Drug Application for Intravenous Contepo (fosfomycin) for Injection". Dublin. |
2019-12-20 |
| Nabriva Therapeutics plc. (12/20/19). "Press Release: Nabriva Therapeutics Announces $20 Million Registered Direct Offering". Dublin & King of Prussia, PA. |
2019-12-20 |
| Zelluna Immunotherapy AS. (12/19/19). "Press Release: Zelluna Immunotherapy Appoints Namir Hassan as Chief Executive Officer". Oslo. |
2019-12-19 |
| Pathios Therapeutics Ltd.. (12/18/19). "Press Release: Pathios Closes US$8.8m Series A and Appoints Stuart Hughes as CEO". Oxford. |
2019-12-18 |
| Sixfold Bioscience Ltd.. (12/17/19). "Press Release: Sixfold Bioscience Awarded Two Innovate UK Grants". |
2019-12-17 |
| Flagship Pioneering. (12/16/19). "Press Release: Flagship Pioneering Strengthens Leadership with Appointment of Paul Biondi as Executive Partner". Cambridge, MA. |
2019-12-16 |
| GlaxoSmithKline plc. (12/16/19). "Press Release: Pivotal DREAMM-2 Study Demonstrated a Clinically Meaningful Overall Response Rate with Belantamab Mafodotin (GSK2857916) for Patients with relapsed/refractory Multiple Myeloma". London. |
2019-12-16 |
| Start Codon Ltd.. (12/11/19). "Press Release: Start Codon and One Nucleus Partner to Support UK Life Science Ecosystem. Start Codon Cohort Companies to Receive One Nucleus Membership Benefits". Cambridge. |
2019-12-11 |
| Charles River Laboratories International, Inc.. (12/10/19). "Press Release: Charles River Announces Strategic Partnership with Bit Bio, Increasing Portfolio of Translational Drug Discovery Technologies". Wilmington, MA. |
2019-12-10 |
| Creoptix AG. (12/10/19). "Press Release: Creoptix Appoints Line Stigen Raquet as Chief Executive Officer". Wädenswil (Zurich). |
2019-12-10 |
| Owlstone Medical Ltd.. (12/10/19). "Press Release: Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure". Cambridge. |
2019-12-10 |
| Markes International Ltd.. (12/10/19). "Press Release: Markes Becomes Licensed World Commercial Supplier of Thin-Film Solid-Phase Microextraction (TF-SPME)". |
2019-12-10 |
| Epidarex Capital. (12/9/19). "Press Release: Epidarex Exeed Founded by Epidarex Capital to Advance Early Stage, Highly Innovative Life Science Assets". Edinburgh. |
2019-12-09 |
| BC Platforms. (12/6/19). "Press Release: BC Platforms Partners with Leading European Genomics Service Provider Center Life & Brain to Expand Genotyping Services Across Europe". Zürich & Boston, MA. |
2019-12-06 |
| Jasper Therapeutics, Inc.. (12/6/19). "Press Release: Jasper Therapeutics Launches with $35 Million Series A Financing to Develop and Commercialize Innovative Conditioning Agents and Therapies to Transform Curative Hematopoietic Cell Transplants". Palo A |
2019-12-06 |
| Unibio International plc. (12/4/19). "Press Release: Mitsubishi Corporation Invests in, and Partners with, Unibio". London & Copenhagen. |
2019-12-04 |
| Lunac Therapeutics Ltd.. (12/2/19). "Press Release: Lunac Therapeutics Led Project Awarded £3.14 Million under Innovate UK Biomedical Catalyst Programme, to Develop Next-generation Anticoagulant". Leeds. |
2019-12-02 |
![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo-2019.png){kind=logo}
Date![Picture [iito] – Putting Information into Context 650x65px](/banner/iito-20181119-650-065-iito-business-intelligence-putting-information-into-context.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
